Catalysts for $NVS
563 tracked
Sep 16, 2014
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Sep 16, 2014
approval
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Aug 25, 2014
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Aug 13, 2014
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Jul 3, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jul 3, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jun 6, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jun 6, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
May 22, 2014
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
May 8, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
May 8, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Apr 17, 2014
approval
KESIMPTA (OFATUMUMAB) — FDA approval
KESIMPTA
→
Feb 28, 2014
approval
TRILEPTAL (OXCARBAZEPINE) — FDA approval
OXCARBAZEPINE
→
Jan 22, 2014
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
Jan 16, 2014
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 16, 2014
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 16, 2014
approval
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Jan 9, 2014
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Jan 8, 2014
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
Dec 26, 2013
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
Nov 8, 2013
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Nov 8, 2013
approval
TEGRETOL (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
Oct 30, 2013
approval
GLEEVEC (IMATINIB MESYLATE) — FDA approval
Imatinib Mesylate Shilpa
→
Sep 24, 2013
approval
KESIMPTA (OFATUMUMAB) — FDA approval
KESIMPTA
→
Jul 29, 2013
approval
TEGRETOL-XR (CARBAMAZEPINE) — FDA approval
carbamazepine ER
→
May 29, 2013
approval
TAFINLAR (DABRAFENIB MESYLATE) — FDA approval
dabrafenib mesylate ODT
→
May 29, 2013
approval
MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
Spexotras
→
May 3, 2013
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
May 3, 2013
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→
May 3, 2013
approval
SANDIMMUNE (CYCLOSPORINE) — FDA approval
Restasis
→